FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved Genentech's supplemental application for Cellcept (mycophenolate mofetil), under NDA 050722, confirming a change/update via a supplemental subm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

SUPPL AP for CELLCEPT (MYCOPHENOLATE MOFETIL)